share_log

Guggenheim Downgrades Travere Therapeutics to Neutral

Moomoo 24/7 ·  Mar 27 06:49

Guggenheim analyst Vamil Divan downgrades Travere Therapeutics (NASDAQ:TVTX) from Buy to Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment